NTRA ▼ -1.8% - Natera, Inc.
$NTRA - Signatera™ Genome with Phased and Structural Variants Highlighted in ESMO Presidential Symposium, Supporting the Critical Role of MRD-Guided Treatment in Bladder Cancer
27-OCT-2026 07:54 AM ET
Share this post
More filings for $NTRA
NTRA ▲ +0.3% - Natera, Inc.Oct 26, 2026NTRA ▼ -2.8% - Natera, Inc.Oct 18, 2026NTRA ▲ +0.6% - Natera, Inc.Oct 9, 2026NTRA ▲ +0.6% - Natera, Inc.Oct 9, 2026NTRA ▼ -0.9% - Natera, Inc.Oct 7, 2026NTRA ▲ +1.0% - Natera, Inc.Oct 6, 2026
View full $NTRA filing history →💬 Comments
Loading comments…
Leave a comment